EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Hesitancy Toward the First COVID-19 Vaccine Booster Dose: A Cross-Sectional Study in Morocco

Fatima Zahra Chellat iD, Nassiba Bahra, Zakia Marsou, Marwa El Baldi, Soumaya Benmaamar, Nabil Tachfouti, Nada Otmani, Mohamed Berraho, Karima El Rhazi

Journal of Primary Care & Community Health · 2025

DOI: 10.1177/21501319251348145 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Fatima Zahra Chellat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sidi Mohamed Ben Abdallah University, Fez, Morocco. Hauptthemen laut MEDLINE: COVID-19, Vaccination Hesitancy, COVID-19 Vaccines, Immunization, Secondary. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID-19 pandemic has posed significant global health challenges, requiring mass vaccination to reduce severe illness and mortality. Despite strong evidence supporting booster dose safety and efficacy, uptake remains low due to widespread hesitancy. This study aims to comprehensively explore the factors contributing to first COVID-19 booster vaccine hesitancy among the general population in Morocco.

Methods

A cross-sectional study was conducted among 574 participants from primary healthcare centers in Fez, Morocco, between April 2022 and April 2023. Data were collected using a structured questionnaire based on the WHO SAGE framework, assessing socio-demographic, contextual, individual, group, and vaccine-specific determinants. Statistical analyses included chi-squared tests and multivariate logistic regression ( P < .05).

Results

Hesitancy toward the first booster dose was reported by 66.2% of participants. Vaccine-specific concerns were the strongest predictor (Adjusted Odds Ratio [AOR] = 27.6; 95% Confidence Interval [CI] = [11.1-68.3]; P < .001), followed by contextual factors (AOR = 7.8; 95% CI = [4.0-15.4]; P < .001) and individual/group determinants (AOR = 3.0; 95% CI = [1.6-5.6]; P = .001). Younger age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Vaccination HesitancyCOVID-19 VaccinesImmunization, SecondaryHumansMoroccoCross-Sectional StudiesFemaleMaleAdultMiddle AgedYoung AdultAdolescentSurveys and QuestionnairesAgedSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Moroccofirst booster dosehesitancyvaccine

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Sidi Mohamed Ben Abdallah University, Fez, Morocco.

ORCID-Profile: Fatima Zahra Chellat

Zitieren

APA

Chellat, F. Z., Bahra, N., Marsou, Z., El Baldi, M., Benmaamar, S., Tachfouti, N., Otmani, N., Berraho, M., & El Rhazi, K. (2025). Hesitancy Toward the First COVID-19 Vaccine Booster Dose: A Cross-Sectional Study in Morocco. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251348145

Vancouver

Chellat FZ, Bahra N, Marsou Z, El Baldi M, Benmaamar S, Tachfouti N, et al. Hesitancy Toward the First COVID-19 Vaccine Booster Dose: A Cross-Sectional Study in Morocco. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251348145

BibTeX
@article{Chellat2025,
  author = {Chellat, Fatima Zahra and Bahra, Nassiba and Marsou, Zakia and El Baldi, Marwa and Benmaamar, Soumaya and Tachfouti, Nabil and Otmani, Nada and Berraho, Mohamed and El Rhazi, Karima},
  title = {Hesitancy Toward the First COVID-19 Vaccine Booster Dose: A Cross-Sectional Study in Morocco},
  journal = {Journal of Primary Care & Community Health},
  year = {2025},
  doi = {10.1177/21501319251348145}
}
Kostenlos starten →